巻頭カラー
p.6 Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling
NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, andUnited States for the period 2016-2030. J Hepatol. 2018;69(4):896-904.
p.6 Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis
and management of nonalcoholic fatty liver disease: Practice guidance from the American
Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.
p.6,7 Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, et al. Down-regulationof SREBP-1c is associated with the development of burned-out NASH. J Hepatol.
2010;53(4):724-31.
p.11 Chaston TB, Dixon JB. Factors associated with percent change in visceral versus
subcutaneous abdominal fat during weight loss: findings from a systematic review.
International journal of obesity (2005). 2008;32(4):619-28.
p.12 Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin
resistance. Nature reviews Endocrinology. 2017;13(9):509-20.
p.13 Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism inhealth and disease. Nature reviews Endocrinology. 2017;13(10):572-87.
p.14 Kadowaki S, Tamura Y, Someya Y, Takeno K, Kaga H, Sugimoto D, et al. Fatty Liver Has
Stronger Association With Insulin Resistance Than Visceral Fat Accumulation in Nonobese
Japanese Men. Journal of the Endocrine Society. 2019;3(7):1409-16.
p.15 Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, et al. Donor
complications associated with living donor liver transplantation in Japan. Transplantation.
2009;88(1):110-4.
p.15 Makuuchi M. Living donor liver transplantation: looking back at my 30 years ofexperience. Surgery today. 2019;49(4):288-94.

第1章
p.42 Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al.
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.
Hepatology. 2010;51(1):121-9.
p.42 Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas
B, Gonzalez-Fabian L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces
Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367-78.e5; quiz e145.
p.46 Chaston TB, Dixon JB. Factors associated with percent change in visceral versus
subcutaneous abdominal fat during weight loss: findings from a systematic review.
International journal of obesity (2005). 2008;32(4):619-28.

p.49 Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primarycare-led weight management for remission of type 2 diabetes (DiRECT): an open-label, clusterrandomised trial. Lancet. 2018;391(10120):541-51.
p.51 Wansink B, Chandon P. Meal size, not body size, explains errors in estimating the calorie
content of meals. Annals of internal medicine. 2006;145(5):326-32.
p.54 An R. Beverage Consumption in Relation to Discretionary Food Intake and Diet Quality
among US Adults, 2003 to 2012. Journal of the Academy of Nutrition and Dietetics.
2016;116(1):28-37.
p.54 Yamada M, Murakami K, Sasaki S, Takahashi Y, Okubo H. Soft drink intake is associatedwith diet quality even among young Japanese women with low soft drink intake. Journal of
the American Dietetic Association. 2008;108(12):1997-2004.
p.54 Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial
sweeteners

induceglucoseintolerancebyaltering

thegut

microbiota.

Nature.

2014;514(7521):181-6.
p.58 西森 栄, 尾形 哲, 高杉 一, 依田 と, 大井 さ, 関口 憲, et al. 糖質制限食は 2 型糖尿病に伴う非アルコール性脂肪性肝疾患をカロリー制限食と同等に改善させる. 糖尿病.
2018;61(5):297-306.
p.60 Maeda H, Katsuki T, Akaike T, Yasutake R. High correlation between lipid peroxide
radical and tumor-promoter effect: suppression of tumor promotion in the Epstein-Barrvirus/B-lymphocyte system and scavenging of alkyl peroxide radicals by various vegetable
extracts. Japanese journal of cancer research : Gann. 1992;83(9):923-8.
p.62 Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, et al.
Carcinogenicity of consumption of red and processed meat. The Lancet Oncology.
2015;16(16):1599-600.
p.63 Godos J, Micek A, Brzostek T, Toledo E, Iacoviello L, Astrup A, et al. Egg consumption
and cardiovascular risk: a dose-response meta-analysis of prospective cohort studies.
European journal of nutrition. 2021;60(4):1833-62.
p.66 Elizabeth L, Machado P, Zinöcker M, Baker P, Lawrence M. Ultra-Processed Foods and
Health Outcomes: A Narrative Review. Nutrients. 2020;12(7).
p.67 Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, et al. Ultra-Processed
Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled
Trial of Ad Libitum Food Intake. Cell metabolism. 2019;30(1):67-77.e3.
p.69 Iwayama K, Kurihara R, Nabekura Y, Kawabuchi R, Park I, Kobayashi M, et al. Exercise
Increases 24-h Fat Oxidation Only When It Is Performed Before Breakfast. EBioMedicine.
2015;2(12):2003-9.
p.76 Nemoto K, Gen-no H, Masuki S, Okazaki K, Nose H. Effects of high-intensity interval
walking training on physical fitness and blood pressure in middle-aged and older people. Mayo
Clin Proc. 2007;82(7):803-11.

第2章
p.91 Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism inhealth and disease. Nature reviews Endocrinology. 2017;13(10):572-87.
p.99 Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID19: a systematic review and meta-analysis. Metabolism: clinical and experimental.
2020;113:154378.
p.100 Joint FAOWHOUNUECoE, Protein R, Food, Agriculture Organization of the United N,
World Health O, United Nations U. Energy and protein requirements : report of a Joint
FAO/WHO/UNU Expert Consultation [held in Rome from 5 to 17 October 1981]. Geneva:
World Health Organization; 1985.
p.104 Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, et al. Down-regulationof SREBP-1c is associated with the development of burned-out NASH. J Hepatol.
2010;53(4):724-31.
p.105 Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United
Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896-904.
P106 Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis
and management of nonalcoholic fatty liver disease: Practice guidance from the American
Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.
p.106 Burra P, Becchetti C, Germani G. NAFLD and liver transplantation: Disease burden,current management and future challenges. JHEP reports : innovation in hepatology.
2020;2(6):100192.
p.108 Machado MV, Diehl AM. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology.
2016;150(8):1769-77.
p.111 Jang C, Hui S, Lu W, Cowan AJ, Morscher RJ, Lee G, et al. The Small Intestine Converts
Dietary Fructose into Glucose and Organic Acids. Cell metabolism. 2018;27(2):351-61.e3.
p.112 Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United
Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896-904.
p.113

AnguloP,

KleinerDE,

Dam-Larsen

S,

Adams

LA,

Bjornsson

ES,

Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is
Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology. 2015;149(2):389-97.e10.
p.113 Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic
experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55(7):434-8.
p.114 Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, et al.
Successful living-related partial liver transplantation to an adult patient. Lancet.
1994;343(8907):1233-4.

p.115 Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, et al. Donor
complications associated with living donor liver transplantation in Japan. Transplantation.
2009;88(1):110-4.
p.116 日本肝移植学会. 肝移植症例登録報告. 移植. 2021;56(3):217-33.
p.118 Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: themultiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-46.
p.127 岡上 武, 水野 雅. 肝機能検査、肝障害について─健診における問題点 . 総合健診.
2015;42(2):307-12.
p.128

AnguloP,

KleinerDE,

Dam-Larsen

S,

Adams

LA,

Bjornsson

ES,

Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is
Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology. 2015;149(2):389-97.e10.
p.129 Ishiba H, Sumida Y, Tanaka S, Yoneda M, Hyogo H, Ono M, et al. The novel cutoff points
for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multicenter study. J Gastroenterol. 2018;53(11):1216-24.
p.129 Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, et al. Diagnostic
accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A
systematic review and meta-analysis. J Hepatol. 2021;75(4):770-85.
p.130 Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, et al. Antidiabetic
Therapy in the Treatment of Nonalcoholic Steatohepatitis. International journal of molecularsciences. 2020;21(6).
p.131 Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD
development and therapeutic strategies. Nat Med. 2018;24(7):908-22.
p.134 伊藤裕. メタボリックドミノとは-生活習慣病の新しいとらえ方. 日本臨牀. 2003;61:18423.
p.134 伊藤 裕. 14）メタボリックドミノと先制医療. 日本内科学会雑誌. 2018;107(9):1913-20.
第3章
p.140 Nanri A, Mizoue T, Noda M, Takahashi Y, Kato M, Inoue M, et al. Rice intake and type2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective
Study. The American journal of clinical nutrition. 2010;92(6):1468-77.
p.140 Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: themultiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-46.
p.140 Hu EA, Pan A, Malik V, Sun Q. White rice consumption and risk of type 2 diabetes:meta-analysis and systematic review. BMJ (Clinical research ed). 2012;344:e1454.
p.150 Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose
and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):106375.

p.154 WHO Guidelines Approved by the Guidelines Review Committee. Guideline: Sugars
Intake for Adults and Children. Geneva: World Health Organization
Copyright © World Health Organization, 2015.; 2015.
p.154 Powell LM, Chriqui JF, Khan T, Wada R, Chaloupka FJ. Assessing the potential
effectiveness of food and beverage taxes and subsidies for improving public health: asystematic review of prices, demand and body weight outcomes. Obesity reviews : an official
journal of the International Association for the Study of Obesity. 2013;14(2):110-28.
p.155 シ ン ガ ポ ー ル 保 健 省 https://hpb.gov.sg/healthy-living/food-beverage/nutri-grade 、Neelakantan N, Park SH, Chen GC, van Dam RM. Sugar-sweetened beverage consumption,weight gain, and risk of type 2 diabetes and cardiovascular diseases in Asia: a systematic
review. Nutrition reviews. 2021;80(1):50-67.
p.161 Jang C, Wada S, Yang S, Gosis B, Zeng X, Zhang Z, et al. The small intestine shields theliver from fructose-induced steatosis. Nature metabolism. 2020;2(7):586-93.
p.167 O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology.
2010;51(1):307-28.
p.168 Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets.
Gastroenterology. 2011;141(5):1572-85.
p.176 Egawa H, Ueda Y, Kawagishi N, Yagi T, Kimura H, Ichida T. Significance ofpretransplant abstinence on harmful alcohol relapse after liver transplantation for alcoholic
cirrhosis in Japan. Hepatol Res. 2014;44(14):E428-36.
p.177 Higuchi S, Matsushita S, Muramatsu T, Murayama M, Hayashida M. Alcohol andaldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcoholism, clinicaland experimental research. 1996;20(3):493-7.
p.178 尾﨑米厚, 文 金. アルコールの疫学─わが国の飲酒行動の実態とアルコール関連問題による社会的損失のインパクト. 医学のあゆみ. 2020;274(1):34-9.
p.182 Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. Results ofa prospective study of acute liver failure at 17 tertiary care centers in the United States.
Annals of internal medicine. 2002;137(12):947-54.
p.183 恩地 森, 滝川 一, 村田 洋, 小島 裕, 橋本 直, 久持 顕, et al. 民間薬および健康食品による薬物性肝障害の調査. 肝臓. 2005;46(3):142-8.
p.185 滝川 一. 薬物性肝障害の診断と治療. 日本内科学会雑誌. 2015;104(5):991-7.
p.187 Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG Clinical Guideline:
Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol.
2021;116(5):878-98.
p.188 Yoshimura N. [Epidemiology of bone and joint disease - the present and future - .
Epidemiology of lumbar spondylosis in Japan : the ROAD study]. Clinical calcium.
2014;24(5):665-8.
p.192 Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence ofmetabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--asystematic review and meta-analysis. Schizophrenia bulletin. 2013;39(2):306-18.
p.196 Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, et al. Risk factors foradverse drug events among nursing home residents. Archives of internal medicine.
2001;161(13):1629-34.
p.197 Stoehr GP, Lu SY, Lavery L, Bilt JV, Saxton JA, Chang CC, et al. Factors associatedwith adherence to medication regimens in older primary care patients: the Steel Valley Seniors
Survey. The American journal of geriatric pharmacotherapy. 2008;6(5):255-63.
p.198 金子 一. 経口補水療法--わが国における現状と今後の展望 (ミニ特集 小児の輸液療法).
小児科臨床. 2008;61(1):13-23.
第4章
p.208 日本消化器病学会関連研究会慢性便秘の診断・治療研究会, 日本消化器病学会. 慢性便秘症診療ガイドライン: 南江堂; 2017. xv, 95p p.
p.208 Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic
Constipation. Gastroenterology. 2020;158(5):1232-49.e3.
p.209 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesityassociatedgut

microbiome

withincreasedcapacityforenergyharvest.

Nature.

2006;444(7122):1027-31.
p.216 西森 栄, 尾形 哲, 高杉 一, 依田 と, 大井 さ, 関口 憲, et al. 糖質制限食は 2 型糖尿病に伴う非アルコール性脂肪性肝疾患をカロリー制限食と同等に改善させる . 糖尿病.
2018;61(5):297-306.
p.221 Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic
Constipation. Gastroenterology. 2020;158(5):1232-49.e3.
p.224 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, et al. The Roleof Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. International
journal of molecular sciences. 2021;22(15).
p.225 Kessoku T, Imajo K, Kobayashi T, Ozaki A, Iwaki M, Honda Y, et al. Lubiprostone inpatients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled,phase 2a trial. The lancet Gastroenterology & hepatology. 2020;5(11):996-1007.
第5章
p.236 Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, Kurosaki M, et al. The epidemiologyof NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting
analysis, 1995-2040. Hepatology international. 2021;15(2):366-79.
p.236 Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, et al. Sarcopenia is associatedwith significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic
fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology. 2016;63(3):776-

86.
p.236 Shida T, Oshida N, Suzuki H, Okada K, Watahiki T, Oh S, et al. Clinical andanthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan.
Hepatol Res. 2020;50(9):1032-46.
p.237 Kawaguchi T, Shima T, Mizuno M, Mitsumoto Y, Umemura A, Kanbara Y, et al. Risk
estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic
markers. PLoS One. 2018;13(1):e0185490.
p.238 Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs.
resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol.
2017;66(1):142-52.
p.240 Martens EA, Lemmens SG, Westerterp-Plantenga MS. Protein leverage affects energy
intake of high-protein diets in humans. The American journal of clinical nutrition.
2013;97(1):86-93.
p.241 Gosby AK, Conigrave AD, Lau NS, Iglesias MA, Hall RM, Jebb SA, et al. Testing protein
leverage in lean humans: a randomised controlled experimental study. PLoS One.
2011;6(10):e25929.
p.242 Gosby AK, Conigrave AD, Raubenheimer D, Simpson SJ. Protein leverage and energy
intake. Obesity reviews : an official journal of the International Association for the Study ofObesity. 2014;15(3):183-91